Browsing: Biosimilar
In June, the Supreme Court overturned the decades-old Chevron doctrine that empowered a federal agency’s “reasonable interpretation of ambiguous federal…
Beginning in 2023, five years after their European counterparts, patients in the United States prescribed the autoimmune disease treatment Humira…